Aehr Test Systems free cash flow AEHR
Cash from operations less capital spending, by quarter and over the last twelve months, from 2010.
- Last 12 months, to May 29, 2026
- −$5.4M
- Latest quarter, Q4 FY26
- $1.7M
- Fiscal year 2026
- −$5.4M
Aehr Test Systems' free cash flow was −$5.4M over the twelve months to May 29, 2026.
In its latest quarter, Q4 FY26, it was $1.7M.
Free cash flow over time
Fiscal year by fiscal year
| Fiscal year | Free cash flow | Change |
|---|---|---|
| FY2026 | −$5.4M | n/a |
| FY2025 | −$12.4M | −1331% |
| FY2024 | $1M | −88% |
| FY2023 | $8.6M | +692% |
| FY2022 | $1.1M | n/a |
| FY2021 | −$2.9M | n/a |
| FY2020 | −$2.2M | n/a |
| FY2019 | −$5.8M | n/a |
| FY2018 | −$1.9M | n/a |
| FY2017 | −$5M | n/a |
| FY2016 | −$7.2M | n/a |
| FY2015 | −$2.4M | n/a |
| FY2014 | −$946K | n/a |
| FY2013 | −$437K | n/a |
| FY2012 | −$4.9M | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | Free cash flow | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q4 FY26 | $1.7M | n/a | −$5.4M | |
| Q3 FY26 | −$3.8M | n/a | −$12.2M | |
| Q2 FY26 | −$1.6M | n/a | −$11.7M | |
| Q1 FY26 | −$1.7M | −177% | −$16.2M | |
| Q4 FY25 | −$5.1M | −535% | −$12.4M | |
| Q3 FY25 | −$3.3M | n/a | −$6.1M | |
| Q2 FY25 | −$6.2M | n/a | −$5.9M | |
| Q1 FY25 | $2.2M | −40% | −$427K | |
| Q4 FY24 | $1.2M | −75% | $1M | |
| Q3 FY24 | −$3.1M | n/a | $4.5M | |
| Q2 FY24 | −$701K | n/a | $6.4M | |
| Q1 FY24 | $3.6M | −33% | $6.9M |
Against its peers
Companies in Hardware, Equipment & Parts nearest Aehr Test Systems' size, closest first, today.
| Company | Free cash flow yield |
|---|---|
| AEHRAehr Test Systems | −0.3% |
| CTSCTS | 6.0% |
| ALNTAllient | 1.8% |
| BHEBenchmark Electronics | 5.4% |
| ITRIItron | 10.0% |
| OLEDUniversal Display | 5.5% |
| BDCBelden | 5.2% |
| VSHVishay Intertechnology | −0.2% |
| VREXVarex Imaging | −2.6% |
| TRNSTranscat | 3.3% |
| FEIMFrequency Electronics | −0.0% |
| Peer median | 4.3% |
What the free cash flow tells you
Cash from operations minus capital spending. The cash the company could hand back or reinvest.
Seasonal and lumpy quarter to quarter. The TTM view is the one to trust.
More on Aehr Test Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.